Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Safely Treating Prostate Cancer and Lowering the Risk of Recurrence Using Novel Radiation Therapy | |
|
| |
A recent Phase I/II clinical trial has shown that a new combination of radiation therapies escalates radiation doses to safely and effectively treat prostate cancer. It also lowers the risk of recurrence with minimal radiation exposure to nearby healthy tissue and organs. The therapies were developed at Virginia Commonwealth University Massey Cancer Center.
Recently published in the journal Brachytherapy, a novel treatment protocol designed by Michael Hagan, M.D., Ph.D., radiation oncologist at VCU Massey Cancer Center, that combines intensity-modulated radiation therapy with high-dose rate (HDR) brachytherapy was tested on 26 prostate cancer patients. Intensity-modulated radiation therapy uses computer-controlled linear accelerators to modulate the intensity of an external radiation beam to more accurately deliver radiation to tumors. HDR brachytherapy is an internal form of radiation therapy that uses small radioactive pellets implanted near the tumor.
"Recent studies have shown that both higher daily doses and higher total doses of radiation are better than standard doses in controlling prostate cancer, but these higher doses may be associated with higher rates of bladder and bowel complications," says the study's lead author Mitchell Anscher, M.D., Florence and Hyman Meyers Chair of Radiation Oncology and program co-leader of Radiation Biology and Oncology at VCU Massey Cancer Center.
"Our study was designed to reduce radiation exposure to nearby healthy tissue and organs and we were pleased to find that this unique dosing schedule is safe and effective."The toxicity of the therapy was relatively low and all 26 patients were able to complete treatment. The treatment required only one HDR brachytherapy implant, and all participants were treated as outpatients. After 4.5 years, none of the patients relapsed and the rate of long-term side effects was low.
"Our goal is to improve outcomes for our patients, so we are continually researching ways to reduce unnecessary radiation exposure to healthy tissues and make treatments shorter and more manageable. We're hopeful our findings will lead to better tumor control rates and fewer complications for men with prostate cancer," says Anscher.Moving forward, the researchers plan to continue exploring prostate cancer therapies using higher dose rates and shorter treatment times. The next step will likely be a four-treatment study utilizing stereotactic body radiosurgery, a technique popular with brain cancer that provides higher accuracy and requires fewer treatments by focusing high-powered X-rays on a very small area.
Source-Eurekalert
| |
|
|
More News on: Radiotherapy, Prostate Cancer, X-Ray, Cancer and Homeopathy, Check your prostate gland, Prostatitis Symptom Score Calculator, Trans-Urethral Resection of the Prostate, Hodgkins Lymphoma, Non-Hodgkins Lymphoma, Reiki and Pranic Healing
 Comment & Contribute
|
Related Links
Cervical Cancer - Overview
Cervical cancer is a slowly progressing disease, which affects the lining of the mouth of the uterus, known as cervix ...
Thyroid Cancer - Symptoms - Risk Factors - Diagnosis - Treatment - Prevention
"Shaped like a butterfly she sits within the neck," that's what an anonymous poet wrote about the thyroid gland but it can become cancerous and ...
Top Thirty Quick and Easy Health Tips
Follow these quick and easy health tips to stay active and healthy all through your ...
Cancer Related News
Link Between Agent Orange Exposure and Prostate Cancer
A new study has now linked the exposure to Agent Orange and lethal forms of prostate cancer among the US Veterans. Published early online in ...
Tumour Growth Mechanism Goes a Step Further
New study suggests that loss of a particular tumour-suppressing protein causes abnormal growth of tumours of the brain and nervous system. ...
Link Between Skin Cancer and Lower Risk of Alzheimer's Disease Identified
According to a recent study people who have skin cancer are at a reduced risk of developing Alzheimer's disease. The link does not apply to melanoma, ...
Molecular Profiling Timely for Tailoring Therapy Shown By First Prospective Trial
Patients, and their physicians, are eager to jump into next-era cancer care analysis of an individual's tumor to find and target genetic mutations ...
Broad Support for Rationing of Some Types of Cancer Care Found By Penn Medicine Study
According to results, the majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to ...
Study Finds Women in 40s Continue to Undergo Routine Mammograms Despite New Recommendations
Researchers at Johns Hopkins found that despite new national guidelines, women in their 40s continued to undergo routine breast cancer screening. ...
- Health News Index
|
|
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Link Between Agent Orange Exposure and Prostate Cancer |
| » | Tumour Growth Mechanism Goes a Step Further |
| » | Link Between Skin Cancer and Lower Risk of Alzheimer's Disease Identified |
| » | Molecular Profiling Timely for Tailoring Therapy Shown By First Prospective Trial |
| » | Broad Support for Rationing of Some Types of Cancer Care Found By Penn Medicine Study |
| More Cancer News | |
|
Ask an Expert
